Ascend Biopharmaceuticals Ltd is a limited by shares Australian public company. Located at VIC 3205 since 2020-10-20 the company is, as the updated on 2021-12-16 ABN database shows, registered. The company has been registered for Goods & Services Tax since 2006-12-11. Known company numbers for Ascend Biopharmaceuticals Ltd are as follows: ACN - 106265098, Australian Business Number - 45106265098. Ascend Biopharmaceuticals Ltd has been the company name since 2013-10-03. Their official company name changed on 2012-07-16 to Ascend Biopharmaceuticals Pty Ltd. The company had used this name up until 2013-10-03. Additionally they had used Igavax Pty Ltd from 2006-12-11 to 2012-07-16. This Australian public company was previously located in VIC 3084 (from 2007-11-07 to 2020-10-20), VIC 3084 (from 2006-12-11 to 2007-11-07).
| Status | From | To |
|---|---|---|
| Active | 2006/12/11 | current |
| Name | From | To |
|---|---|---|
| Ascend Biopharmaceuticals Ltd | 2013/10/03 | current |
| Ascend Biopharmaceuticals Pty Ltd | 2012/07/16 | 2013/10/03 |
| Igavax Pty Ltd | 2006/12/11 | 2012/07/16 |
| Location | From | To |
|---|---|---|
| VIC 3205 | 2020/10/20 | current |
| VIC 3084 | 2007/11/07 | 2020/10/20 |
| VIC 3084 | 2006/12/11 | 2007/11/07 |
| Status | From | To |
|---|---|---|
| Registered | 2006/12/11 | current |
Advertisements
General information:
| Patent status: |
Sealed What happens 3 months after acceptance, assuming there are no oppositions filed. The Status 'sealed' was replaced with 'granted' with IP reform implementation, but from a systems perspective the two statuses are identical. |
| Patent type: | STANDARD |
International Patent Classification:
| IPC Mark: | C12N 15/00 |
| Section code: | C - chemistrymetallurgy |
| Class code: | 12 - biochemistry; beer; spirits; wine; vinegar; microbiology; enzymology; mutation or genetic engineering |
| Subclass code: | N - micro-organisms or enzymes; compositions thereof (biocides, pest repellants or attractants, or plant growth regulators containing micro-organisms, viruses, microbial fungi, enzymes, fermentates, or substances produced by, or extracted from, micro-organisms or animal material a01n0063000000; medicinal preparations a61k; fertilisers c05f); propagating, preserving, or maintaining micro-organisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000) |
| Main group code: | 15 - mutation or genetic engineering; dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; use of hosts therefor (mutants or genetically engineered micro-organisms c12n0001000000, c12n0005000000, c12n0007000000; new plants a01h; plant reproduction by tissue culture techniques a01h0004000000; new animals a01k0067000000; use of medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases, gene therapy a61k0048000000; peptides in general c07k) |
IP Australia process information:
| Expiry date: | 2031/05/10 |
International Patent Classification:
| IPC Mark: | A61K 47/36 |
| Section code: | A - human necessities |
| Class code: | 61 - medical or veterinary science; hygiene |
| Subclass code: | K - preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l) |
| Main group code: | 47 - medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives |
| Subgroup code: | 36 - polysaccharides; derivatives thereof |
IP Australia process information:
| Expiry date: | 2021/06/06 |
General information:
| Patent status: |
Sealed What happens 3 months after acceptance, assuming there are no oppositions filed. The Status 'sealed' was replaced with 'granted' with IP reform implementation, but from a systems perspective the two statuses are identical. |
| Patent type: | NPE |
International Patent Classification:
| IPC Mark: | C12N 15/00 |
| Section code: | C - chemistrymetallurgy |
| Class code: | 12 - biochemistry; beer; spirits; wine; vinegar; microbiology; enzymology; mutation or genetic engineering |
| Subclass code: | N - micro-organisms or enzymes; compositions thereof (biocides, pest repellants or attractants, or plant growth regulators containing micro-organisms, viruses, microbial fungi, enzymes, fermentates, or substances produced by, or extracted from, micro-organisms or animal material a01n0063000000; medicinal preparations a61k; fertilisers c05f); propagating, preserving, or maintaining micro-organisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000) |
| Main group code: | 15 - mutation or genetic engineering; dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; use of hosts therefor (mutants or genetically engineered micro-organisms c12n0001000000, c12n0005000000, c12n0007000000; new plants a01h; plant reproduction by tissue culture techniques a01h0004000000; new animals a01k0067000000; use of medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases, gene therapy a61k0048000000; peptides in general c07k) |
IP Australia process information:
| Expiry date: | 2031/05/10 |
Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.